Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease
Open Access
- 27 March 2000
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 35 (5) , 1103-1115
- https://doi.org/10.1016/s0735-1097(00)00554-4
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery diseaseThe Lancet, 1990
- Angioscopic observation of the coronary luminal changes induced by percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1989
- Aspirin, Heparin, or Both to Treat Acute Unstable AnginaNew England Journal of Medicine, 1988
- Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1988
- The platelet membrane glycoprotein IIb-IIIa complexBlood, 1988
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985
- Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model.Circulation Research, 1985
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983